INS and type 2 diabetes mellitus: Currently, patients with T2DM are treated symptomatically with various drugs, including exogenous insulin itself, insulin sensitizers, GLP-1 analogues and DPP4 inhibitors that increase insulin secretion, as well as SGL2 inhibitors, which promote glycosuria.